Author:
Plantinga Theo S.,van Maren Wendy W. C.,van Bergenhenegouwen Jeroen,Hameetman Marjolijn,Nierkens Stefan,Jacobs Cor,de Jong Dirk J.,Joosten Leo A. B.,van't Land Belinda,Garssen Johan,Adema Gosse J.,Netea Mihai G.
Abstract
ABSTRACTThe use of probiotics as a food supplement has gained tremendous interest in the last few years as beneficial effects were reported in gut homeostasis and nutrient absorption but also in immunocompromised patients, supporting protection from colonization or infection with pathogenic bacteria or fungi. As a treatment approach for inflammatory bowel diseases, a suitable probiotic strain would ideally be one with a low immunogenic potential. Insight into the immunogenicities and types of T-cell responses induced by potentially probiotic strains allows a more rational selection of a particular strain. In the present study, the bacterial strainsBifidobacterium breve(NumRes 204),Lactobacillus rhamnosus(NumRes1), andLactobacillus casei(DN-114 001) were compared concerning their capacity to induce inflammatory responses in terms of cytokine production by human and mouse primary immune cells. It was demonstrated that theB. brevestrain induced lower levels of the proinflammatory cytokine gamma interferon (IFN-γ) than the testedL. rhamnosusandL. caseistrains. BothB. breveand lactobacilli induced cytokines in a Toll-like receptor 9 (TLR9)-dependent manner, while the lower inflammatory profile ofB. brevewas due to inhibitory effects of TLR2. No role for TLR4, NOD2, and C-type lectin receptors was apparent. In conclusion, TLR signaling is involved in the differentiation of inflammatory responses between probiotic strains used as food supplements.
Publisher
American Society for Microbiology
Subject
Microbiology (medical),Clinical Biochemistry,Immunology,Immunology and Allergy
Cited by
51 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献